152 related articles for article (PubMed ID: 30583033)
1. Fasting plasma glucose variability levels and risk of adverse outcomes among patients with type 2 diabetes: A systematic review and meta-analysis.
Zhao Q; Zhou F; Zhang Y; Zhou X; Ying C
Diabetes Res Clin Pract; 2019 Feb; 148():23-31. PubMed ID: 30583033
[TBL] [Abstract][Full Text] [Related]
2. Optimal cutoff values of fasting plasma glucose (FPG) variability for detecting retinopathy and the threshold of FPG levels for predicting the risk of retinopathy in type 2 diabetes: A longitudinal study over 27 years.
Takao T; Inoue K; Suka M; Yanagisawa H; Iwamoto Y
Diabetes Res Clin Pract; 2018 Jun; 140():228-235. PubMed ID: 29625141
[TBL] [Abstract][Full Text] [Related]
3. Is fasting glucose variability a risk factor for retinopathy in people with type 2 diabetes?
Zoppini G; Verlato G; Targher G; Casati S; Gusson E; Biasi V; Perrone F; Bonora E; Muggeo M
Nutr Metab Cardiovasc Dis; 2009 Jun; 19(5):334-9. PubMed ID: 18571393
[TBL] [Abstract][Full Text] [Related]
4. Visit-to-Visit Variability of Fasting Plasma Glucose and the Risk of Cardiovascular Disease and All-Cause Mortality in the General Population.
Wang A; Liu X; Xu J; Han X; Su Z; Chen S; Zhang N; Wu S; Wang Y; Wang Y
J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29187392
[TBL] [Abstract][Full Text] [Related]
5. The effect of fasting plasma glucose variability on the risk of retinopathy in type 2 diabetic patients: retrospective long-term follow-up.
Takao T; Ide T; Yanagisawa H; Kikuchi M; Kawazu S; Matsuyama Y
Diabetes Res Clin Pract; 2010 Sep; 89(3):296-302. PubMed ID: 20416966
[TBL] [Abstract][Full Text] [Related]
6. The Accuracy of Diagnostic Methods for Diabetic Retinopathy: A Systematic Review and Meta-Analysis.
Martínez-Vizcaíno V; Cavero-Redondo I; Álvarez-Bueno C; Rodríguez-Artalejo F
PLoS One; 2016; 11(4):e0154411. PubMed ID: 27123641
[TBL] [Abstract][Full Text] [Related]
7. Impact of Visit-to-Visit Fasting Plasma Glucose Variability on the Development of Type 2 Diabetes: A Nationwide Population-Based Cohort Study.
Kim JA; Lee JS; Chung HS; Roh E; Lee YB; Hong SH; Kim NH; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi KM
Diabetes Care; 2018 Dec; 41(12):2610-2616. PubMed ID: 30254081
[TBL] [Abstract][Full Text] [Related]
8. The effects of fasting plasma glucose variability and time-dependent glycemic control on the long-term risk of retinopathy in type 2 diabetic patients.
Takao T; Ide T; Yanagisawa H; Kikuchi M; Kawazu S; Matsuyama Y
Diabetes Res Clin Pract; 2011 Feb; 91(2):e40-2. PubMed ID: 21035886
[TBL] [Abstract][Full Text] [Related]
9. Fasting Glucose Variation Predicts Microvascular Risk in ACCORD and VADT.
Zhou JJ; Koska J; Bahn G; Reaven P
J Clin Endocrinol Metab; 2021 Mar; 106(4):1150-1162. PubMed ID: 33367811
[TBL] [Abstract][Full Text] [Related]
10. Trajectories of fasting plasma glucose variability and mortality in type 2 diabetes.
Lee CL; Sheu WH; Lee IT; Lin SY; Liang WM; Wang JS; Li YF
Diabetes Metab; 2018 Mar; 44(2):121-128. PubMed ID: 29032950
[TBL] [Abstract][Full Text] [Related]
11. Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies.
Wong TY; Liew G; Tapp RJ; Schmidt MI; Wang JJ; Mitchell P; Klein R; Klein BE; Zimmet P; Shaw J
Lancet; 2008 Mar; 371(9614):736-43. PubMed ID: 18313502
[TBL] [Abstract][Full Text] [Related]
12. Visit-to-visit fasting plasma glucose variability is an important risk factor for long-term changes in left cardiac structure and function in patients with type 2 diabetes.
Tang X; Zhong J; Zhang H; Luo Y; Liu X; Peng L; Zhang Y; Qian X; Jiang B; Liu J; Li S; Chen Y
Cardiovasc Diabetol; 2019 Apr; 18(1):50. PubMed ID: 30992008
[TBL] [Abstract][Full Text] [Related]
13. Visit-to-visit variation of fasting plasma glucose is a predictor of hip fracture in older persons with type 2 diabetes: the Taiwan Diabetes Study.
Chiang JI; Li TC; Li CI; Liu CS; Meng NH; Lin WY; Yang SY; Chen HJ; Lin CC
Osteoporos Int; 2016 Dec; 27(12):3587-3597. PubMed ID: 27363401
[TBL] [Abstract][Full Text] [Related]
14. Fasting plasma glucose variability and all-cause mortality among type 2 diabetes patients: a dynamic cohort study in Shanghai, China.
Xu D; Fang H; Xu W; Yan Y; Liu Y; Yao B
Sci Rep; 2016 Dec; 6():39633. PubMed ID: 28004765
[TBL] [Abstract][Full Text] [Related]
15. [Influence of plasma glucose variability and age on onset of diabetic retinopathy in diabetic patients analysis of results of long-term outpatient follow-up for 30 years or more].
Takao T; Okayasu M; Yanagisawa H; Kikuchi M
Nihon Ronen Igakkai Zasshi; 2009; 46(6):528-36. PubMed ID: 20139649
[TBL] [Abstract][Full Text] [Related]
16. Fasting plasma glucose variability as a risk factor of retinopathy in Type 2 diabetic patients.
Gimeno-Orna JA; Castro-Alonso FJ; Boned-Juliani B; Lou-Arnal LM
J Diabetes Complications; 2003; 17(2):78-81. PubMed ID: 12614973
[TBL] [Abstract][Full Text] [Related]
17. Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study.
Muggeo M; Zoppini G; Bonora E; Brun E; Bonadonna RC; Moghetti P; Verlato G
Diabetes Care; 2000 Jan; 23(1):45-50. PubMed ID: 10857967
[TBL] [Abstract][Full Text] [Related]
18. Variability of fasting plasma glucose and the risk of painful diabetic peripheral neuropathy in patients with type 2 diabetes.
Pai YW; Lin CH; Lee IT; Chang MH
Diabetes Metab; 2018 Mar; 44(2):129-134. PubMed ID: 29459007
[TBL] [Abstract][Full Text] [Related]
19. Annual fasting plasma glucose variation increases risk of cancer incidence and mortality in patients with type 2 diabetes: the Taichung Diabetes Study.
Lin CC; Li CI; Liu CS; Lin WY; Chen CC; Yang SY; Lee CC; Li TC
Endocr Relat Cancer; 2012 Aug; 19(4):473-83. PubMed ID: 22544890
[TBL] [Abstract][Full Text] [Related]
20. The product of fasting plasma glucose and triglycerides improves risk prediction of type 2 diabetes in middle-aged Koreans.
Lee JW; Lim NK; Park HY
BMC Endocr Disord; 2018 May; 18(1):33. PubMed ID: 29843706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
